Mild to moderate discomfort is common in the first week
For patients exploring this category for the first time, the key distinction is that GLP-1 therapy is a prescription, physician-supervised therapy not a wellness supplement
Treatment approaches, including the use of Semaglutide, are based on the specific needs and characteristics of each patient
You shouldnt take tirzepatide medications or Wegovy if you have: A personal or family history of medullary thyroid carcinoma (MTC) A history of multiple endocrine neoplasia syndrome type 2 (MEN 2) A serious allergic reaction to tirzepatide, semaglutide , or any of the ingredients in these medications Your clinician will determine if GLP-1 medications are right for you if you have a history of: Pancreatitis , kidney problems, or gallbladder disease, including gallstones Diabetic retinopathy Gastroparesis or other serious digestive conditions Tirzepatide and Wegovy are also not for people who are pregnant, planning to become pregnant, or breastfeeding
Match your vial size to your dose schedule to minimize waste
The 60.3% symptom recurrence rate after discontinuation confirms that ongoing treatment appears necessary for sustained benefit